Ожирение у молодых женщин как первое проявление метаболического синдрома: поиск эффективных методов коррекции

1. Barret-Connor EL. Obesity, atherosclerosis, and coronary artery disease. Annal Intern Med 1985; 103: 1010–19.
2. Borsika A Rabin, Tegan K. Boehmer, Ross C. Brownson Cross-national comparison of environmental and policy correlates of obesity in Europe. Eur J Public Health 2007; 17 (1): 53–61.
3. Campbell IW, Howlett CS. Worldwide experience of metformin as a glucose-lowering agent: a meta-analysis. Diabetes Metab Rev 1995; 11 (Suppl. 1): S57–S62.
4. Caruso A, Paradisi G, Ferrazzani S et al. Effect of maternal carbohydrate metabolism in fetal growth. Obstet Gynecol 1998; 92: 8–12.
5. Fleming R et al. Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. J Clin Endocrinol Metab 2002; 87: 569–74.
6. Gokcel A, Gumurdulu Y, Karakose H et al. Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity. Diabetes Obesity and Metabolism 2002; 4: Issue 1.
7. Hubert HB, Fienleib M et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 986–77.
8. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev 1994; 74: 761–811.
9. Kliegman R, Gross T, Morton S, Dunnington R. Intrauterine growth and postnatal fasting metabolism in infants of obese mothers. J Pediatr 1984; 104: 601–7.
10. Kocak M et al. Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome. Fertil Steril 2002; 77: 101–6.
11. Lee A, Morley J. Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes. Obes Res 1998; 6: 47–53.
12. Mannucci E, Ognibene A, Cremasco F. Effect of metformin on glucagon-like peptide 1 (glp-1) and leptin levels in obese nondiabetic subjects. Diabetes Care 2001; 24 (3): 489–94.
13. Moghetti P et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 2000; 85: 139–46.
14. Morin-Papunen LC et al. Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study. J Clin Endocrinol Metab 2000; 85: 3161–8.
15. Nestler JE et al. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 1998; 338: 1876–80.
16. Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c17α activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 1996; 335: 617–23.
17. Norman RJ et al. Metformin and intervention in polycystic ovary syndrome. Med J Aust 2001; 174: 580–3.
18. Obesity and overweight What are overweight and obesity? WHO Fact sheet N311 September 2006 http://www.who.int/mediacentre/factsheets/fs311/en/
19. Obesity: preventing and managing the global epidemic Report of a WHO Consultation Geneva, World Health Organization, 2004.
20. Ogburn PL, Goldstein M, Walker J, Stonestreet BS. Prolonged hyperinsulinemia reduces plasma fatty acid levels in the major lipid groups in fetal sheep. Am J Obstet Gynecol 1989; 161: 728–32.
21. Paolisso G, Amato L, Eccellente R et al. Effect of metformin on food intake in obese subjects. Eur J Clin Invest 1998; 28: 441–6.
22. Pasquali R et al. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 2000; 85: 2767–74.
23. Pettitt DJ, Nelson RG, Saad MF et al. Diabetes and obesity in the offspring of Pima Indian women with diabetes during pregnancy. Diabetes Care 1993; 16: 310–4.
24. Ravelli ACJ, van der Meulen JHP, Bleker OP et al. Body size of newborn babies after prenatal exposure to the Dutch famine of 1944–45. In: Prenatal exposure to the Dutch famine and glucose tolerance and obesity at age 50. University of Amsterdam. 1999; 5: 51–62.
25. Ravelli ACJ, van der Meulen JHP, Osmond C et al. Obesity after prenatal exposure to famine in men and women at the age of 50. In: Prenatal exposure to the Dutch Famine and glucose tolerance and obesity at age 50. University of Amsterdam. 1999; 5: 75–87.
26. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities – the role of insulin resistance and sympathoadrenal system. New Engl J Med 1996; 334: 374–81.
27. Reilly JJ, Jackson DM et al. Total energy expenditure and physical activity in young Scottish children: mixed longitudinal study. Lancet 2004; 363: 211–2.
28. Rouru J, Hupponen R, Pesonen U, Koulu M. Subchronic treatment with metformin produces anorectic effect and reduces hyperinsulinemia in genetically obese Zucker rats. Life Sci 1992; 50: 1813–20.
29. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? Br Med J 2002; 325: 157–60.
30. Sebire NJ, Jolly M et al. Maternal obesity and pregnancy outcome: a study of 287 213 pregnancies in London. Int J Obes Relat Metab Disord 2001; 25: 1175–82.
31. Sermer M, Naylor CD et al. The Toronto Tri-Hospital Gestational Diabetes Project. A preliminary review. Diabetes Care 1998; 21: B33–B42.
32. Stadtmauer LA et al. Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors. Fertil Steril 2001; 75: 505–9.
33. Stampfer MJ, Hu FB et al. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000; 343: 16–22.
34. Stein Z, Susser M. The Dutch famine, 1944–45, and the reproductive process. I. Effects on six indices at birth. Pediatr Res 1975; 9: 70–6.
35. Williams D. Pregnancy: a stress test for life. Curr Opin Obstet Gynecol 2003; 5 (6): 465–71.
36. Лекарственные средства. Справочник лекарственных средств, отпускаемых по рецепту врача (фельдшера) при оказании дополнительной бесплатной медицинской помощи отдельным категориям граждан, имеющим право на получение государственной социальной помощи. Под ред. Р.У.Хабриева, А.Г.Чучалина. 2005; 2.
37. Чернуха Г.Е. Ожирение как фактор риска нарушений репродуктивной системы у женщин. Consilium Medicum 2007; 9 (6): 84–6.
38. Cleophas Ton J. Experimental evidence of selective antagonistic action ofNebivolol onfit-adrenergic receptors. J Clin Med 1998; II: 1–8.
39. Gao Y et al. Nebivolol induces endotelium-dependent relaxations of canine coronary arteries. J Cardiovasc Pharmacol 1991; 17: 964–9.
40. Cockcroft JR, Chowenczyk PH, Brett SE et al. Nebivolol vasodilates human forearm vasculate: evidence for L-arginine/NO-dependent mechanism. J Parmacol Exp Therapeutics 1995; 274 (3): 1067–71.

О.Н.Ткачева, А.Ю.Галяутдинова, Н.К.Рунихина